Immediate Impact
50 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Extracellular vesicles in cancer´s communication: messages we can read and how to answer
2025 Standout
Works of Manana Elia being referenced
Extracellular vesicle-derived non-coding RNAs to predict outcome in patients with triple-negative breast cancer (TNBC) with residual disease (RD).
2023
Clinical and biomarker results from phase I/II study of PI3K inhibitor BYL 719 (alpelisib) plus nab-paclitaxel in HER2-negative metastatic breast cancer.
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Manana Elia | 141 | 215 | 107 | 16 | 329 | |
| Robin Brenner | 197 | 271 | 104 | 12 | 350 | |
| Pedro Exman | 96 | 240 | 93 | 19 | 363 | |
| Orsolya Rusz | 97 | 192 | 140 | 19 | 305 | |
| J Simony | 104 | 166 | 123 | 21 | 338 | |
| Zora Baretta | 116 | 149 | 84 | 14 | 325 | |
| R. Dent | 151 | 249 | 87 | 12 | 331 | |
| Matteo Repetto | 107 | 153 | 117 | 23 | 327 | |
| Daniela Petriella | 146 | 131 | 182 | 13 | 344 | |
| Nobumoto Tomioka | 127 | 199 | 98 | 26 | 341 | |
| Brigitte Poirot | 120 | 160 | 167 | 12 | 363 |
All Works
Loading papers...